Morten Leth Jepsen

Morten Leth Jepsen

Auto-generated profile, based on publicly available information

Morten Leth Jepsen

Dr. M. Leth Jepsen, A. Willumsen, Dr. C. Mazzoni, Prof. A. Boisen, Dr. L. Hagner Nielsen, Dr. M. Dufva, The Danish National Research Foundation and Villum Foundation's Center for Intelligent Drug Delivery and Sensing Using Microcontainers and Nanomechanics (IDUN), Department of Health Technology, Technical University of Denmark, Ørsteds Plads 345C, Kgs. Lyngby, 2800, Denmark

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2013 in Expert Review of Molecular Diagnostics
Verified
Journal Article
Closed access
BKBirgitta R Knudsen
Birgitta R Knudsen
MJMorten Leth Jepsen
Morten Leth Jepsen
YHYi-Ping Ho
Yi-Ping Ho
Enzymes are essential in the human body, and the disorder of enzymatic activities has been associated with many different diseases and stages of disease. Luminescent semiconductor nanocrystals, also known as quantum dots (QDs), have garnered great attention in molecular diagnostics. Owing to their superior optical properties, tunable and narrow emissions, stable brightness and long lifetime, QD-based enzyme activity measurement has demonstrated improved detection sensitivity, which is considered particularly valuable for early disease diagnosis. Recent studies have also shown that QD-based nanosensors are capable of probing multiple enzyme activities simultaneously. This review highlights the current development of QD-based nanosensors for enzyme detection. The enzyme-QD hybrid system, equipped with unique electronic, optical and catalytic properties, is envisioned as a potential solution in addressing challenges in diagnostics and therapeutics.

3 May 2017 in RSC Advances
Verified
Journal Article
Open access
PDF file
CTCinzia Tesauro
Cinzia Tesauro
BFB. Ferrando
B. Ferrando
XMX. Ma
X. Ma
MJM. L. Jepsen
M. L. Jepsen
AIA. K. R. Ivarsen
A. K. R. Ivarsen
YHYi-Ping Ho
Yi-Ping Ho
Isolation of subcellular fractions from a limited amount of clinical sample is imperative for the continuous advancement of biological and clinical research.

8 December 2018 in Biopolymers
Verified
Journal Article
Closed access
PDF file
MJMorten Leth Jepsen
Morten Leth Jepsen
LNLine Hagner Nielsen
Line Hagner Nielsen
ABAnja Boisen
Anja Boisen
KAKristoffer Almdal
Kristoffer Almdal
MDMartin Dufva
Martin Dufva

10 May 2020 in Advanced Biosystems
Verified
Journal Article
Closed access
PDF file
MJMorten Leth Jepsen
Morten Leth Jepsen
AWAndreas Willumsen
Andreas Willumsen
CMChiara Mazzoni
Chiara Mazzoni
ABAnja Boisen
Anja Boisen
LNLine Hagner Nielsen
Line Hagner Nielsen
MDMartin Dufva
Martin Dufva

25 March 2013 in Sensors
Verified
Journal Article
Open access
PDF file
LMLærke Bay Marcussen
Lærke Bay Marcussen
MJMorten Leth Jepsen
Morten Leth Jepsen
EKEmil Laust Kristoffersen
Emil Laust Kristoffersen
OFOskar Franch
Oskar Franch
JPJoanna Proszek
Joanna Proszek
BKBirgitta Knudsen
Birgitta Knudsen
Sensors capable of quantitative real-time measurements may present the easiest and most accurate way to study enzyme activities. Here we present a novel DNA-based sensor for specific and quantitative real-time measurement of the enzymatic activity of the essential human enzyme, topoisomerase I. The basic design of the sensor relies on two DNA strands that hybridize to form a hairpin structure with a fluorophore-quencher pair. The quencher moiety is released from the sensor upon reaction with human topoisomerase I thus enabling real-time optical measurement of enzymatic activity. The sensor is specific for topoisomerase I even in raw cell extracts and presents a simple mean of following enzyme kinetics using standard laboratory equipment such as a qPCR machine or fluorimeter. Human topoisomerase I is a well-known target for the clinically used anti-cancer drugs of the camptothecin family. The cytotoxic effect of camptothecins correlates directly with the intracellular topoisomerase I activity. We therefore envision that the presented sensor may find use for the prediction of cellular drug response. Moreover, inhibition of topoisomerase I by camptothecin is readily detectable using the presented DNA sensor, suggesting a potential application of the sensor for first line screening for potential topoisomerase I targeting anti-cancer drugs.

13 November 2015 in Nanoscale
Verified
Journal Article
Closed access
PDF file
MJMorten Leth Jepsen
Morten Leth Jepsen
CHCharlotte Harmsen
Charlotte Harmsen
AGAdwait Anand Godbole
Adwait Anand Godbole
VNValakunja Nagaraja
Valakunja Nagaraja
BKBirgitta Knudsen
Birgitta Knudsen
YHYi-Ping Ho
Yi-Ping Ho
We present a quantum dot based DNA nanosensor specifically targeting the cleavage step in the reaction cycle of the essential DNA-modifying enzyme, mycobacterial topoisomerase I. The design takes advantages of the unique photophysical properties of quantum dots to generate visible fluorescence recovery upon specific cleavage by mycobacterial topoisomerase I. This report, for the first time, demonstrates the possibility to quantify the cleavage activity of the mycobacterial enzyme without the pre-processing sample purification or post-processing signal amplification. The cleavage induced signal response has also proven reliable in biological matrices, such as whole cell extracts prepared from Escherichia coli and human Caco-2 cells. It is expected that the assay may contribute to the clinical diagnostics of bacterial diseases, as well as the evaluation of treatment outcomes.